This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Sept. 18, 2013 /PRNewswire/ -- LUGPA, representing more than 2,000 urologists nationwide, and Henry Schein Cares, the global corporate social responsibility program of
Henry Schein, Inc., have partnered again this year to raise awareness among families across the country of the importance of putting prostate cancer check-ups on the calendar for the men in their lives. September – for many families, back-to-school time for the kids – is Prostate Cancer Awareness Month. To create more public awareness about the importance of early detection of prostate cancer to save men's lives, LUGPA and
Henry Schein have re-launched an educational initiative to put a prostate cancer check-up for dad on American families' back to school list.
"Prostate cancer remains the second-leading cause of cancer death in American men. As children return to school this year, we want families to be reminded that with early detection, this disease is almost always curable," said Dr.
Deepak A. Kapoor, a prominent
New York urologist and president of LUGPA. "Take this opportunity to remind your loved ones to have a discussion with their doctor to determine if they need a prostate check-up. Together we can help ensure that generations of men are there to see their children and grandchildren, grow up and go back to school each year."
According to Dr. Kapoor, one out of six American men will have prostate cancer in their lifetime; the incidence is even higher for African-American men, those with a family history of prostate cancer and men with a higher baseline PSA in their 40s. Prostate cancer is the most common non-skin malignancy diagnosed in men; with early detection efforts, the death rate from prostate cancer has decreased by over 40 percent in
the United States.
Dr. Kapoor stated, "The most recent PSA screening guidelines – released just last month – state definitively that PSA screening reduces cancer mortality and reduces the risk of being diagnosed with or developing advanced prostate cancer. Furthermore, it is recommended that men between the ages of 40-45 obtain a baseline PSA, and that all men with a life expectancy of 10 years or more be screened, regardless of age." "Unfortunately, there are no symptoms during the early stages of prostate cancer, when the disease is most treatable," said Kapoor. "Despite improvement in patient education and awareness, many men still fall through the cracks. When the disease is caught early, the 10-year survival is almost 99 percent. We support the rights of men to access appropriate, life-saving prostate cancer screening, and we encourage men to have a conversation with their doctors regarding whether screening is appropriate for them."